Capecitabine for the treatment of advanced gastric cancer

  • Technology appraisal guidance
  • TA191
  • Published: 
Download guidance (PDF)

7 Sources of evidence considered by the Committee

The Evidence Review Group (ERG) report for this appraisal was prepared by Centre for Reviews and Dissemination, University of York:

  • Norman G, Soares M, Peura P, et al., Capecitabine for the treatment of advanced gastric cancer, February 2010

The following organisations accepted the invitation to participate in this appraisal as consultees and commentators. They were invited to comment on the draft scope. Manufacturers, or sponsors, were also invited to make written submissions. Professional or specialist and patient or carer groups gave their expert views on capecitabine by providing a written statement to the Committee. Manufacturers, or sponsors, professional or specialist and patient or carer groups and other consultees have the opportunity to appeal against the final appraisal determination.

Manufacturer or sponsor:

  • Roche Products (capecitabine)

Professional or specialist and patient or carer groups:

  • Cancer Research UK

  • Macmillan Cancer Support

  • Royal College of Nursing

  • Royal College of Physicians, Medical Oncology Joint Special Committee

Other consultees:

  • Department of Health

  • Welsh Assembly Government

Commentator organisations (did not provide written evidence and without the right of appeal):

  • Department of Health, Social Services and Public Safety for Northern Ireland

  • National Institute for Health Research Health Technology Assessment Programme

  • NHS Centre for Reviews & Dissemination and Centre for Health Economics – York

  • NHS Quality Improvement Scotland

The following individuals were selected from clinical specialist and patient expert nominations from the non-manufacturer or sponsor consultees and commentators. They gave their expert personal view on capecitabine by providing oral evidence to the Committee.

  • Dr Alicia Okines, Clinical Research Fellow, nominated by The Royal College of Physicians – clinical specialist

  • Dr Anne L Thomas, Senior Lecturer in Medical Oncology, nominated by The Royal College of Physicians – clinical specialist

  • Abrar Hussain-Qureshi, nominated by Macmillan Cancer Support – patient expert

Representatives from the following manufacturer or sponsor attended Committee Meetings. They contributed only when asked by the Committee chair to clarify specific issues and comment on factual accuracy.

  • Roche Products

ISBN: 978-1-4731-6522-9